COLUMBUS, Ohio, July 23 (Nationwide Times) — For most people, the takeaway is modest: a small Ohio State study suggests a specially made tomato drink may lower some inflammation markers, but it does not prove that ordinary tomato juice will do the same or that the drink can prevent disease.
What did the study find?
According to the study abstract indexed in PubMed and published in Molecular Nutrition & Food Research, 12 adults with obesity drank either a tomato-soy beverage or a low-carotenoid tomato juice in a crossover design. Each person had two 6-ounce servings a day for four weeks, then a washout period before switching drinks.
After the tomato-soy drink period, the study reported significant decreases in three cytokines, or immune signaling proteins, linked to chronic inflammation: IL-5, IL-12p70 and GM-CSF. Another marker, TNF-α, trended downward but did not meet conventional statistical significance. The abstract also said plasma lycopene rose 2.48-fold after the tomato-soy beverage.
What made the drink different?
The study did not test regular store-bought tomato juice. The PubMed abstract says the beverage was made from tomatoes bred to contain high levels of lycopene and was fortified with soy isoflavones. The comparison drink was a low-carotenoid tomato juice.
The abstract also reported shared changes in the urine metabolome after both interventions, which the authors said suggests some tomato-driven effects may happen independent of lycopene alone.
What does that mean for daily choices?
The study tracks biology, not long-term health outcomes. It does not show whether the drink lowers the risk of heart disease, diabetes or other illness over time. Because the trial included only 12 adults and lasted four weeks, it is too small to support broad dietary advice.
That makes the result best read as an early clue, not as a medical recommendation.
Has tomato juice been studied before?
An earlier randomized study listed on PubMed and done at Tehran University of Medical Sciences found tomato juice reduced some inflammatory markers in overweight or obese female students. In that study, IL-8 and TNF-α fell in the intervention group, and IL-6 decreased in obese participants. That research was separate from the Ohio State study and involved a different population and drink.
For readers, the main message is simple: a specially formulated tomato drink may affect inflammation signals in the body, but the evidence is still too limited to tell people to change their diets based on this study alone.
